July 14, 2020
Penumbra announced appointments for two newly created positions: Corey L. Teigen, M.D., as chief scientific officer and James F. Benenati, M.D., FSIR, as chief medical officer.
Penumbra notes Dr. Teigen joins immediately as CSO and will contribute his extensive scientific and clinical expertise to ongoing and future research and development efforts. “In my radiology practice, I’ve seen firsthand the challenges medical practitioners face while treating difficult medical conditions,” Dr. Teigen said. “At Penumbra, I have a profound opportunity to change the course of healthcare delivery for people living with vascular disease. I feel privileged to join Penumbra’s unparalleled group of talented engineers and leaders, and I look forward to contributing my scientific knowledge to help solve challenging medical problems.”
Dr. Benenati will join Penumbra on September 1, 2020, as CMO, and will contribute to clinical and medical affairs strategies and advise upon global commercialization and market development activities.
“I’m excited to join Penumbra at this very important time for the company, where it’s poised for growth, as it moves into the next generation of intelligent clot removal and expand into rehabilitation with the recent launch of the REAL system,” Dr. Benenati said. “Penumbra has changed the landscape of healthcare by providing truly innovative solutions for a wide realm of medical challenges. In this next phase, Penumbra is set to broaden its reach on a global scale, and I am thrilled to join this excellent team and help accelerate the impact of its products.”
“I am thrilled we are bringing Lightning 12, the most advanced technology for aspiration thrombectomy, to the peripheral interventional community,” said Adam Elsesser, president and chief executive officer, Penumbra. “It is an ideal time for us to welcome Corey and Jim to Penumbra’s leadership team as we progress into our next phase of growth. Their career-long focus on patient care and their innovative mindset are a perfect fit with our vision and culture, which is dedicated to making a fundamental difference in patients’ lives.”
Corey L. Teigen M.D. is a board-certified vascular and interventional radiologist. He is also a researcher and developer of interventional devices. Dr. Teigen received his medical degree from Johns Hopkins University School of Medicine with distinction and did his radiology residency at the Mayo Clinic Rochester, Minnesota. He completed his fellowship at the Miami Cardiac and Vascular Institute, Miami, Florida. He served as Chairman of Interventional Radiology at Sanford Health, Fargo, North Dakota for 25 years. Dr.Teigen has authored numerous publications and has been involved in the development of multiple interventional devices for the treatment of vascular and other diseases.
Teigen has presented more than 100 professional talks sharing lessons learned and successes realized over his 30-year career in the practice of Interventional Radiology. Dr. Teigen’s research has focused on multiple areas including development of the Cordis Incraft stent graft for the endovascular repair of abdominal aneurysm. He has also been involved in the development of intravascular stents, balloons, liquid and coil embolics, inferior vena cava filters, and thrombectomy devices. He has served on the Peripheral Vascular Committee of SIR and was Co-director of the Sanford Health Vascular Institute.
About James F. Benenati, M.D., FSIR: James F. Benenati M.D., FSIR is a board-certified vascular and interventional radiologist. Prior to joining Penumbra, Dr. Benenati practiced interventional radiology at the Miami Cardiac & Vascular Institute at Baptist Hospital in Miami for 30 years, where he has served in multiple positions, including medical director of the noninvasive vascular laboratory and fellowship program director. He is the vice-chairman of the department of interventional radiology and clinical professor of radiology at the Florida International University Herbert Wertheim College of Medicine, Miami. He is also a Collaborative Professor of Radiology at the University of South Florida Morsani College of Medicine. He is past President of the Society of Interventional Radiology (SIR 2011) and past Annual Meeting Chairman for the SIR Annual Meeting in 2005. He has received the highest awards given by the SIR including the SIR Gold Medal and the Charles T. Dotter Award. Dr. Benenati is the founding Medical Director of the Nova Southeastern University Health Sciences BS/ RVT program. He served as President of the Vascular Division for the Intersocietal Accreditation Committee (IAC) and has served for over a decade on the IAC Vascular Testing Board. Over the course of his career, Dr. Benenati has authored more than 120 scientific publications, published numerous book chapters and edited journals and textbooks in interventional radiology. He has lectured nationally and internationally and has been a program director of the International Symposium on Endovascular Technology (ISET) for 30 years. His undergraduate education was at the University of Notre Dame, he attended medical school at the University of South Florida College of Medicine from 1980-1984, he completed a diagnostic radiology residency at Indiana University School of Medicine in 1988, and he completed a fellowship in Cardiovascular and Interventional Radiology at the Johns Hopkins University School of Medicine in 1989.